Study identifier:149902
ClinicalTrials.gov identifier:NCT02300090
EudraCT identifier:N/A
CTIS identifier:N/A
A Real-World Assessment of a COPD Disease Management Support Service (Me & My COPD).
Chronic Obstructive Pulmonary Disease
-
No
-
All
161
Observational
N/A
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Aug 2018 by AstraZeneca
AstraZeneca
-
No locations available
Arms | Assigned Interventions |
---|---|
Intervention group This group of patients (n=250) will receive the digital service (smart phone application and bluetooth inhaler device) in addition to current best care from their healthcare professional. | Device: Test Group Patients receive a mobile phone with the Me & My COPD app installed. Patients also receive a bluetooth inhaler device that is fitted to their usual reliever inhaler. |
Control group This group of patients (n=250) will receive current best care alone. Control patients will not have access to the digital service. | Other: Control Group Patients in the control group receive only standard care; there are no interventions within this group of patients |